Lung cancer screening: Is it time for a change in policy?

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 6, 2007, Pages 441-448

  Mazzone, Peter ^a   Obuchowski, Nancy ^a   Mekhail, Tarek ^a   Meziane, Moulay ^a   Ahmad, Muzaffar ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250180947     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.6.441     Document Type: Article

References (61)

1. The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355:1763-1771.
2. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007; 297:953-961.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-130.
4. Obuchowski N, Modic MT. Whole-body CT screening for cancer and coronary disease: does it pass the test? Cleve Clin J Med 2004; 71:47-56.
5. Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax 1968; 23:414-420.
6. Wilde J. A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR. Eur Respir J 1989; 2:656-662.
7. Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: a 16-year follow-up. J Chronic Dis 1986; 39:453-463.
8. Melamed MR, Flehinger BJ, Zaman MB, et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984, 86:44-53.
9. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984; 130:549-554.
10. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000; 92:1308-1316.
11. Kubik A, Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986; 57:2427-2437.
12. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer. A critique of the Mayo Lung project. Cancer 1991; 67:1155-1164.
13. Patz EF, Swensen SJ, Herndon JE. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: Implications for current mass screening recommendations. J Clin Oncol 2004, 22:2202-2206.
14. Motohiro A, Ueda H, Komatsu H, Yanai N, Mori T. Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan. Lung Cancer 2002; 36:65-69.
15. Sato M, Saito Y, Endo C, et al. The natural history of radiographically occult bronchogenic squamous cell carcinoma. A retrospective study of overdiagnosis bias. Chest 2004; 126:108-113.
16. Bianchi F, Hu J, Pelosi G, et al. Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray. Clin Cancer Res 2004; 10:6023-6028.
17. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004; 22:3099-3103.
18. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006; 98:748-756.
19. Strauss GM, Dominioni L, Jett JR, Freedman M, Grannis FW. Como international conference position statement. Lung cancer screening for early diagnosis 5 years after the 1998 Varese conference. Chest 2005; 127:1146-1151.
20. Manser RL, Dodd M, Byrnes G, Irving LB, Campbell DA. Incidental lung cancers identified at coronial autopsy: implications for over-diagnosis of lung cancer by screening. Respir Med 2005; 99:501-507.
21. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002; 20:911-920.
22. Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest 2000; 117:1568-1571.
23. Heyneman LE, Herndon JE, Goodman PC, Patz EF. Stage distribution in patients with a small (≤ 3 cm) primary nonsmall cell carcinoma. Implication for lung carcinoma screening. Cancer 2001; 92:3051-3055.
24. Wisnivesky JP, Yankelevitz D, Henschke CI. The effect of tumor size on curability of stage I non-small cell lung cancers. Chest 2004; 126:761-765.
25. Mery CM, Pappas AN, Burt BM, et al. Diameter of non-small cell lung cancer correlates with long-term survival. Implications for T stage. Chest 2005; 128:3255-3260.
26. Wisnivesky JP, Yankelvitz D, Henschke CI. Stage of lung cancer in relation to its size. Part 2. Evidence. Chest 2005; 127:1136-1139.
27. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999; 354:99-105.
28. Sone S, Li F, Yang Z-G, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001; 84:25-32.
29. Nawa T, Nakagawa T, Kusano S, et al. Lung cancer screening using low-dose spiral CT. Results of baseline and 1-year follow-up studies. Chest 2002; 122:15-20.
30. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002; 20:911-920.
31. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002; 165:508-513.
32. Diederich S, Wormanns D, Semik M, et al. Screening for early lung cancer with low-dose spiral CT: Prevalence in 817 asymptomatic smokers. Radiology 2002; 222:773-781.
33. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362:593-597.
34. Bastarrika G, Garcia-Velloso MJ, Lozano MD, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005; 171:1378-1383.
35. MacRedmond R, Logan PM, Lee M, et al. Screening for lung cancer using low dose CT scanning. Thorax 2004; 59:237-241.
36. Titola M, Kivisaari L, Huuskonen MS, et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002; 35:17-22.
37. Chong S, Lee KS, Chung MJ, et al. Lung cancer screening with low-dose helical CT in Korea: experiences at the Samsung Medical Center. J Korean Med Sci 2005; 20:402-408.
38. Miller A, Markowitz S, Manowitz A, Miller JA. Lung cancer screening using low-dose high-resolution CT scanning in a high-risk workforce. 3,500 nuclear fuel workers in three US states. Chest 2004; 125:152S-153S.
39. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005; 235:259-265.
40. Fischbach F, Knollmann F, Griesshaber, et al. Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol 2003; 13:2378-2383.
41. Lindell RM, Hartman TE, Swensen SJ, et al. Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population. AJR 2005; 185:126-131.
42. Townsend CO, Clark MM, Jett JR, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 2005; 103:2154-2162.
43. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004 231:440-445.
44. Chirikos TN, Hazelton T, Tockman M, Clark R. Screening for lung cancer with CT. A preliminary cost-effectiveness analysis. Chest 2002; 121:1507-1514.
45. Mahadevia PJ, Fleisher LA, Frick KD, et al. Lung cancer screening with helical computed tomography in older adult smokers. A decision and cost-effectiveness analysis. JAMA 2003; 289:313-322.
46. Wisnivesky JP, Mushlin AI, Sicherman N, Henschke C. The cost-effectiveness of low-dose CT screening for lung cancer. Preliminary results of baseline screening. Chest 2003; 124:614-621.
47. Manser R, Dalton A, Carter R, Graham B, Elwood M, Campbell DA. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 2005; 48:171-185.
48. Bechtel JJ, Kelley WA, Coons TA, et al. Lung cancer detection in patients with airflow obstruction identified in a primary care outpatient practice. Chest 2005; 127:1140-1145.
49. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006; 98:691-699.
50. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guideline for prostate, colorectal, and endometrial cancers. Also: Update 2001 - testing for early lung cancer detection. CA Cancer J Clin 2001; 51:38-75.
51. Aberle DR, Gamsu G, Henschke CI, et al. A consensus statement of the Society of Thoracic Radiology: screening for lung cancer with helical computed tomography. J Thorac Imaging 2001; 16:65-68.
52. Bach PB, Niewoehner DE, Black WC. Screening for lung cancer. The guidelines. Chest 2003; 123:82S-88S.
53. U.S. Preventive Service Task Force. Lung cancer screening: recommendation statement. Ann Intern Med 2004; 140:738-739.
54. Yankelevitz DF, Reeves AP, Kostis WJ, et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000; 217:251-256.
55. Peldschus K, Herzog P, Wood SA, Cheema JI, Costello P, Schoepf J. Computer-aided diagnosis as a second reader. Spectrum of findings in CT studies of the chest interpreted as normal. Chest 2005; 128:1517-1523.
56. Armato SG, Roy AS, MacMahon H, et al. Evaluation of automated lung nodule detection on low-dose computed tomography scans from a lung cancer screening program. Acad Radiol 2005; 12:337-346.
57. Yanagisawa K, Shyr Y, Xu BJ, et al. Proteomic patterns of tumor subsets in non-small-cell lung cancer. Lancet 2003; 362:433-439.
58. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J respir Crit Care Med 2005; 172:1308-1314.
59. Phillips M, Cataneo RN, Cummin ARC, et al. Detection of lung cancer with volatile markers in the breath. Chest 2003; 123:2115-2123.
60. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analysis of exhaled breath. Am J Respir Crit Care Med 2005; 171:1-6.
61. Di Natale C, Macagnano A, Martinelli E, et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectroni 2003; 18:1209-1218.